About this trial
This randomized controlled pretest-posttest experimental study aims to evaluate the effect of virtual reality (VR) on pain and anxiety levels experienced during Pap smear sampling. Although cervical cancer is largely preventable through regular screening, many women avoid Pap smear testing due to anxiety, fear of pain, and discomfort during gynecological examinations. Innovative, non-invasive interventions are needed to improve women's screening experiences and participation rates.
The study will be conducted in a gynecology outpatient clinic with 60 women aged 18-65 years who meet the inclusion criteria and provide informed consent. Participants will be randomly assigned to either the intervention group (VR headset during the procedure) or the control group (standard care). Women in the intervention group will watch a 360° relaxing nature video during the Pap smear procedure. Data will be collected using a Personal Information Form, the State Anxiety Inventory, and the Visual Analog Scale (VAS). The findings may support integrating VR into clinical practice to enhance patient comfort during screening procedures.
Eligibility criteria
Qualifiers
Women aged 18-65 years
Scheduled for a Pap smear procedure
Able to communicate in Turkish
Able to understand and complete the study questionnaires
Disqualifiers
History of severe motion sickness or vertigo
Diagnosed psychiatric disorder affecting anxiety assessment
Use of anxiolytic or sedative medication within 24 hours prior to the procedure
Presence of acute pelvic pain or active vaginal infection
Trial design
Treatments tested in this trial
- Virtual Reality